基因代理IL-6受体抑制与阿托皮性皮肤炎风险增加有关

Sizheng Steven Zhao1, Zenas Z N Yiu2

  • 1Centre for Musculoskeletal Research, School of Biological Sciences, Faculty of Biological Medicine and Health, The University of Manchester, Manchester, United Kingdom.

概括

干白素-6受体 (IL-6R) 抑制剂与阿托皮性皮肤炎 (AD) 的风险增加有关. 遗传分析证实IL-6R信号与AD易感性有因果关系,因此需要临床警.